Xiaoying Sun
- Oncology top 5%
- Molecular Biology
- Immunology top 10%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Topics
- Cancer Genomics and Diagnostics (9 papers)Lung Cancer Treatments and Mutations (6 papers)Cancer Cells and Metastasis (5 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Nature MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Xiaoying Sun
50 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 787
- Molecular Biology 663
- Immunology 376
- Cancer Research 368
- Pulmonary and Respiratory Medicine 259
Countries citing papers authored by Xiaoying Sun
This map shows the geographic impact of Xiaoying Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoying Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoying Sun more than expected).
Fields of papers citing papers by Xiaoying Sun
This network shows the impact of papers produced by Xiaoying Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoying Sun. The network helps show where Xiaoying Sun may publish in the future.
Co-authorship network of co-authors of Xiaoying Sun
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoying Sun. A scholar is included among the top collaborators of Xiaoying Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoying Sun. Xiaoying Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancerbreakdown → | 25 |
| 3 | 11 | |
| 4 | 8 | |
| 5 | 11 | |
| 6 | 7 | |
| 7 | 4 | |
| 8 | 19 | |
| 9 | Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancerbreakdown → | 434 |
| 10 | 31 | |
| 11 | 4 | |
| 12 | 10 | |
| 13 | 32 | |
| 14 | 69 | |
| 15 | 16 | |
| 16 | 25 | |
| 17 | 2 | |
| 18 | 24 | |
| 19 | 26 | |
| 20 | 29 |
About Xiaoying Sun
Xiaoying Sun is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 50 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Oncology (787 citations), Cancer Research (368 citations) and Immunology (376 citations). Xiaoying Sun has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Fei Ma, Binghe Xu, Hongnan Mo, Zhihua Liu, Baolin Liu, Ranran Gao, Hongyan Chen, Yuanyuan Zhang, Qing Chang and Yong Wang. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.